Skip to content
Screener

EBITDA margin at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp
AptarGroup logo
AptarGroupATR
19.3%-2.2pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
60.2%+8.7pp
AVT
AvantorAVTR
10.2%-4.9pp
Dow logo
DowDOW
6.4%-1.4pp
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
23.3%+1.5pp

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.49B+42.8%
Enterprise value$24.37B+43.8%
P/E43.4×+8.2×
P/S7.4×+1.6×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Calculated from West Pharmaceutical Services’s reported figures.

Based on trailing twelve months.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099

FAQ

What is West Pharmaceutical Services's EBITDA margin?
West Pharmaceutical Services (WST) reported EBITDA margin of 25.9% in Q2 2026.
How has West Pharmaceutical Services's EBITDA margin changed year-over-year?
West Pharmaceutical Services's EBITDA margin increased by 3.1% year-over-year, from 25.1% to 25.9%.
What is the long-term trend for West Pharmaceutical Services's EBITDA margin?
Over 5 years (2020 to 2025), West Pharmaceutical Services's EBITDA margin has grown at a 0.6% compound annual growth rate (CAGR), from 23.8% to 24.6%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about West Pharmaceutical Services's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude